Health
Recurrent GBM brain tumors with few mutations respond best to immunotherapy – Duke Department of Neurology
Glioblastoma brain tumors are especially perplexing.
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after theyve grown back, enabling up to 20% of patients to live well beyond predicted survival times.
What causes this effect has long been the pursuit of researchers hoping to harness immunotherapies to extend more lives.
New insights from a team led by Dukes Preston Robert Tisch Brain Tumor Center, including the Neurology Department’s Katherine Peters, MD, PhD, Dina Randazzo,…
-
Business18 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business14 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News14 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News14 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots